Cellestial Health: Venture Capital Funding History

Cellestial Health

To add a bio or update company history, please click update information.

News from Cellestial Health

Cellestial Health raises £515k pre-seed round led by Zinc VC to develop astrocyte-targeting drugs for Parkinson's

9 May 2025

Cellestial Health raises £515k pre-seed round led by Zinc VC to develop astrocyte-targeting drugs for Parkinson's

Cellestial Health is developing small molecule drugs that target astrocytes in the brain, aiming to create new treatments for Parkinson’s disease and other neurodegenerative conditions with limited existing options.

Cellestial Health

Life Sciences
Cambridge, United Kingdom
£515k
cellestialhealth.com
Update Information

More venture news

Basecamp Research
23 Sept 2026
Basecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models
Series CLife Sciences
Big Picture Bio
18 Sept 2026
Big Picture Bio raises a £1.5m pre-seed round led by Kadmos Capital and Exceptional Ventures to design cancer combination therapies
Pre-seedLife Sciences
Eterna Regeneratives
16 Sept 2026
Eterna Regeneratives closes a seed round led by Hoxton Ventures and The Venture Collective to develop keratin-based enamel repair
SeedLife Sciences

Cellestial Health: Venture Capital Funding History

News from Cellestial Health

Cellestial Health raises £515k pre-seed round led by Zinc VC to develop astrocyte-targeting drugs for Parkinson's

More venture news

Basecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models

Big Picture Bio raises a £1.5m pre-seed round led by Kadmos Capital and Exceptional Ventures to design cancer combination therapies

Eterna Regeneratives closes a seed round led by Hoxton Ventures and The Venture Collective to develop keratin-based enamel repair